Blood tests were taken two days before each treatment.
Lymphocytes 2.1/1.3/1.3/1.5
Platelets 139/153/135/214/216
Haemoglobin 103/101/97/104/113
Neutrophils 1.7/1.6/1.0/1.0/0.8
RBC 4.21/3.99/3.93/4.19/4.55
HCT 0.32/0.31/0.30/0.32/0.35
Hoping this is heading in the right direction. Neutrophils are a bit low but hoping they improve now treatment has finished. Is that usually what happens?
Written by
Redkatt
To view profiles and participate in discussions please or .
If you could supply the reference ranges and the change from previous labs it gives folks a point to see where you are relative to where you came from. Sometimes referred to as the trend. Try to think of your test results as a snapshot or a waypoint on a GPS.
That's looking encouragingly usual. Do keep in mind that it's possible to experience late onset neutropenia after anti-CD20 monoclonal antibody treatments (rituximab, obinutuzumab), for up to a year after your last infusion. It's more likely within the first 6 months and more so if you've needed G-CSF injections (filgrasim, neulasta, zarzio, etc.) to support your neutrophil counts during treatment.
Thanks Neil. I’m hoping “encouragingly usual” is promising . They weren’t concerned at the treating hospital with the 0.8 neutrophils so no injections were given. Next blood test is in July. Hopefully neutrophils don’t decrease in this time.
Content on HealthUnlocked does not replace the relationship between you and doctors or other healthcare professionals nor the advice you receive from them.
Never delay seeking advice or dialling emergency services because of something that you have read on HealthUnlocked.